Immediate Impact
24 standout
Citing Papers
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials
2025 Standout
Development and validation of a new algorithm for improved cardiovascular risk prediction
2024 Standout
Works of Ruby Birk being referenced
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ruby Birk | 322 | 246 | 13 | 11 | 332 | ||
| Ferran Chuecos | 277 | 227 | 10 | 13 | 305 | ||
| Gonzalo de Miquel | 320 | 252 | 9 | 13 | 351 | ||
| Rajat Mohindra | 273 | 211 | 3 | 10 | 7 | 296 | |
| Eddie McKnight | 248 | 197 | 4 | 11 | 273 | ||
| Donna Reilly | 256 | 233 | 1 | 7 | 13 | 291 | |
| Fernando J. Martinez | 326 | 219 | 3 | 5 | 6 | 371 | |
| Laura Padullés | 248 | 164 | 10 | 15 | 294 | ||
| Chris Compton | 303 | 248 | 3 | 21 | 315 | ||
| Michael Larbig | 236 | 224 | 2 | 3 | 10 | 302 | |
| Inge Leimer | 274 | 176 | 1 | 9 | 10 | 297 |
All Works
Loading papers...